when will they restructure us? no other company has a whole sales force selling one drug, just a matter of time!
they just restructured the Brovana sales team in July. I think you are good for a while. Keep growing Brovana at 25% annually and you will be just fine.
I am amazed this force is still intact. If in fact Brovana is still coved by medicare part B the HHC'cs (Lincare, Apria etc) do a large part of the selling. Believe me I sold Xopenex when it was covered under medicare. It is a cakewalk. Much simpler than selling in the Tier 3/NDC managed care coverage challenges. Eliminate medicare coverage and this product would evaporate. Wake up Sunovion management.
Sorry. Should have said NDC block. That means that a product will not be covered by a managed care plan. Tier 3 is a non-preferred product. You dont" have to know those terms when selling Brovana.
oooh! Big bad rep: you don't know SQUAT...if you were so good, WTF are you doing working for Sunovion, you ROBOT!
Only because of the great pay and benefits. I have sold Xopenex and Brovana when covered by Medicare part B. It is a very easy sell. Congrats if you are on the Brovana team. Brovana.com is a great site to highlight all HHC's (Apria etc) and retail chain's that dispense Brovana for medicare part B patients.
Major patent runs out April 2012. Go check Orangebook. Three minor patents giving coverage through 2016 and beyond, actually. Mylan (Dey) actually got a decision from the courts in early October of this year to have at least 2 of them re-examined for validity. You can verify this all yourself if you know how to do a Google search properly.
Mylan's Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist® Patents The following is excerpted from an October 20, 2011 Mylan press release available on its website: Dey Pharma L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), today confirmed that the U.S. Patent and Trademark Office (PTO) has issued Reexamination Certificates for two patents related to Perforomist® (Formoterol Fumarate) Inhalation Solution 20 mcg/2mL vial thereby confirming the validity of these patents. Sepracor, now known as Sunovion Pharmaceuticals, requested the PTO to re-examine these patents, which now has been completed. Mylan Chairman and CEO Robert J. Coury commented: "We are pleased that the successful re-examination of these patents is complete as this only further strengthens our confidence in the intellectual property protecting our Perforomist product as well as our combination product currently in development. We are very excited about continuing to build on our brand division, Dey, which is and will continue to be an important growth driver for Mylan." In addition to the two re-examined and granted patents, Dey owns five other relevant patents, giving it a total of seven U.S. patents which it believes are infringed by Sunovion's Brovana® product. In addition, Dey believes that Teva's Formotorol Fumarate product, which is the subject of an Abbreviated New Drug Application (ANDA) pending before the FDA, infringes several of Dey's U.S. patents. Mylan intends to vigorously defend its intellectual property in the pending patent litigations against Sunovion and Teva. The terms of the patents protecting Perforomist extend into 2021.
Long Acting Beta-2 Agonists are bronchodilators used to treat asthma and COPD. Medication Name Generic Available Discount Programs Arformoterol (Brovana) No The Bronava patent expires in 2012 Formoterol (Foradil, Perforomist, Symbicort*) No The Foradil patent expires in 2017 Salmeterol (Advair**, Serevent) Yes
Pharma reps cannot do task that are outside of the box. Please post instructions on how to do this and they will memorize it and recite the instructions back and nausea. Thanks.
lots of angry posters on here. Likely former pharma reps now slandering who they once were. Clearly the rest of the company is longing for Brovana to fail and with that the former ISS division reps to be let go as well. Perhaps that will happen. But until then, Special Markets will continue to be the top sales force within our organization and most importantly continue to be the highest compensated sales force within Sunovion. Life is good on top.
